STEFANUTTI, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 1.023
EU - Europa 450
AS - Asia 188
AF - Africa 14
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.684
Nazione #
US - Stati Uniti d'America 986
IT - Italia 218
CN - Cina 105
FR - Francia 74
CA - Canada 35
DE - Germania 35
GB - Regno Unito 31
HK - Hong Kong 19
IN - India 18
SE - Svezia 15
IE - Irlanda 11
KR - Corea 10
NL - Olanda 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
TR - Turchia 9
UA - Ucraina 9
RU - Federazione Russa 7
CH - Svizzera 4
CL - Cile 4
ES - Italia 4
IR - Iran 4
JP - Giappone 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
ID - Indonesia 3
PH - Filippine 3
PT - Portogallo 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
EG - Egitto 2
FI - Finlandia 2
LT - Lituania 2
MX - Messico 2
QA - Qatar 2
SG - Singapore 2
TW - Taiwan 2
AT - Austria 1
BT - Bhutan 1
DK - Danimarca 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.684
Città #
Rome 115
Houston 112
Santa Cruz 112
Fairfield 93
Ashburn 63
Woodbridge 52
Ann Arbor 50
Seattle 42
Buffalo 41
Wilmington 32
Cambridge 27
Hangzhou 20
Milan 17
Central District 16
Des Moines 15
Toronto 15
Chicago 14
Stockholm 13
Shanghai 12
Beijing 11
Civitavecchia 11
Dublin 11
Paris 11
New York 10
Bengaluru 9
San Diego 9
Ankara 7
Las Vegas 7
Boardman 6
Clearwater 6
Muizenberg 6
Dallas 5
Los Angeles 5
Ottawa 5
Provo 5
San Francisco 5
Cardiff 4
Hebei 4
Henderson 4
Leawood 4
London 4
Montreal 4
Montréal 4
Seoul 4
Shenyang 4
Tiel 4
Chengdu 3
Newbury Park 3
Overland Park 3
Palo Alto 3
Phoenix 3
Saint Paul 3
Suwon 3
Tokyo 3
Zaragoza 3
Zhengzhou 3
Zurich 3
Andover 2
Ashford 2
Bagumbayan 2
Berlin 2
Boulder 2
Büdelsdorf 2
Cape Town 2
Catania 2
Chongqing 2
Collegno 2
Council Bluffs 2
Denver 2
Doha 2
Fleming Island 2
Greenbank 2
Guangzhou 2
Hackensack 2
Helsinki 2
Jinan 2
Kiev 2
Lake Forest 2
Lakewood 2
Liverpool 2
Longueuil 2
Lucca 2
Moncalieri 2
Mount Olive 2
Mountain View 2
Nanjing 2
Pomezia 2
Quartu Sant'Elena 2
Reston 2
Rieti 2
Riva 2
Rotterdam 2
Saint-Basile-le-Grand 2
San Jose 2
Scranton 2
Taipei 2
Tappahannock 2
Turin 2
University Park 2
Zografou 2
Totale 1.149
Nome #
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolaemia, file e383532a-7679-15e8-e053-a505fe0a3de9 294
Identification and diagnosis of patients with familial chylomicronemia syndrome (FCS): Expert Panel recommendations and proposal of an FCS Score, file e383531d-ec18-15e8-e053-a505fe0a3de9 167
Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia, file e3835317-59bb-15e8-e053-a505fe0a3de9 111
Geometric complexity identifies platelet activation in familial hypercholesterolemic patients, file e383532a-15c7-15e8-e053-a505fe0a3de9 106
Toward an international consensus - integrating lipoprotein apheresis and new lipid-lowering drugs, file e3835318-1ffb-15e8-e053-a505fe0a3de9 105
Evolocumab in pediatric heterozygous familial hypercholesterolemia, file e3835329-a84a-15e8-e053-a505fe0a3de9 99
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score, file e3835324-7408-15e8-e053-a505fe0a3de9 96
Hijacked journals are emerging as a challenge for scholarly publishing, file e383532a-400d-15e8-e053-a505fe0a3de9 96
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - A post-hoc analysis of a Phase 3, single-arm, open-label trial, file e3835313-3041-15e8-e053-a505fe0a3de9 93
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia, file e383532a-1ab4-15e8-e053-a505fe0a3de9 87
A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study, file e3835329-ab4f-15e8-e053-a505fe0a3de9 78
Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia, file e383532a-1eda-15e8-e053-a505fe0a3de9 76
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort, file e383532a-588a-15e8-e053-a505fe0a3de9 44
Hypercholesterolaemia - practical information for non-specialists, file e3835329-d8f9-15e8-e053-a505fe0a3de9 36
Current approach to the diagnosis and treatment of heterozygote and homozygous FH children and adolescents, file e383532d-4f2b-15e8-e053-a505fe0a3de9 34
The 1(st) and the 2(nd) Italian Consensus Conferences on low-density lipoprotein-apheresis. A practical synopsis and update, file e3835317-2aae-15e8-e053-a505fe0a3de9 23
Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis, file e3835324-0b5a-15e8-e053-a505fe0a3de9 18
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a), file e3835329-b76e-15e8-e053-a505fe0a3de9 18
Lomitapide-a microsomal triglyceride transfer protein inhibitor for homozygous familial hypercholesterolemia, file e3835329-b30b-15e8-e053-a505fe0a3de9 17
A three month-old infant with severe hyperchylomicronemia: Molecular diagnosis and extracorporeal treatment, file e3835311-e976-15e8-e053-a505fe0a3de9 16
Lipid profile and left ventricular geometry pattern in obese children, file e3835329-7800-15e8-e053-a505fe0a3de9 16
HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment?, file e3835317-5b6f-15e8-e053-a505fe0a3de9 11
Low density lipoprotein apheresis, file e3835312-1026-15e8-e053-a505fe0a3de9 7
Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9, file e383531d-dead-15e8-e053-a505fe0a3de9 7
Liver Dysfunction Supportive Therapies – From Therapeutic Plasmapheresis to Molecular Adsorbent Recirculating System, file e3835311-c461-15e8-e053-a505fe0a3de9 6
Combined treatment with Dif1stat and diet reduce plasma lipid indicators of moderate hypercholesterolemia more effectively than diet alone: a randomized trial in parallel groups., file e3835311-c81c-15e8-e053-a505fe0a3de9 6
Treatment of Severe Genetic Dyslipidemia: Where Are We Going?, file e3835311-cb56-15e8-e053-a505fe0a3de9 5
Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials, file e383531c-ffd2-15e8-e053-a505fe0a3de9 4
Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis, file e3835324-20f8-15e8-e053-a505fe0a3de9 4
Prevalence of gallstone disease in an Italian adult female population., file e383532d-829c-15e8-e053-a505fe0a3de9 4
Therapeutic Plasmapheresis. A gate to an effective treatment of severe pathological conditions, file e3835311-cb59-15e8-e053-a505fe0a3de9 3
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias, file e3835313-35ec-15e8-e053-a505fe0a3de9 3
Treatment of primary hypertriglyceridemia states - General approach and the role of extracorporeal methods, file e3835313-39ee-15e8-e053-a505fe0a3de9 3
EFFICACY OF ALIROCUMAB IN 1,191 PATIENTS WITH A WIDE SPECTRUM OF MUTATIONS IN GENES CAUSATIVE FOR FAMILIAL HYPERCHOLESTEROLEMIA, file e3835317-2e59-15e8-e053-a505fe0a3de9 3
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature, file e3835323-9cdd-15e8-e053-a505fe0a3de9 3
A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report, file e3835323-b66e-15e8-e053-a505fe0a3de9 3
Lipoprotein apheresis downregulates IL-1α, IL-6 and TNF-α mRNA expression in severe dyslipidaemia, file e3835329-7652-15e8-e053-a505fe0a3de9 3
Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice, file e3835329-8384-15e8-e053-a505fe0a3de9 3
Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study, file e3835329-838d-15e8-e053-a505fe0a3de9 3
A three month-old infant with severe hyperchylomicronemia: Molecular diagnosis and extracorporeal treatment, file e3835311-e975-15e8-e053-a505fe0a3de9 2
Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group 2009 Survey, file e3835312-0e39-15e8-e053-a505fe0a3de9 2
Il trattamento extracorporeo mediante plasma-exchange della sindrome di Raynaud: un caso clinico, file e3835312-2c57-15e8-e053-a505fe0a3de9 2
Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion, file e383531d-dcda-15e8-e053-a505fe0a3de9 2
Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis, file e383531d-f4cc-15e8-e053-a505fe0a3de9 2
The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study, file e383531e-1f45-15e8-e053-a505fe0a3de9 2
The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study, file e383531e-4a32-15e8-e053-a505fe0a3de9 2
ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia?, file e383531e-68c3-15e8-e053-a505fe0a3de9 2
Therapeutic apheresis in pregnancy: three differential indications with positive maternal and fetal outcome, file e3835323-d1b8-15e8-e053-a505fe0a3de9 2
Familial hypercholesterolaemia: the influence of lipoprotein apheresis on choroid and retina. an oct and octa retrospective study, file e3835325-4172-15e8-e053-a505fe0a3de9 2
Homozygous familial hypercholesterolaemia in childhood – The first case report in Southeast Europe, file e3835329-6fb3-15e8-e053-a505fe0a3de9 2
Serum uric acid and left ventricular geometry pattern in obese children, file e3835329-7803-15e8-e053-a505fe0a3de9 2
Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action, file e3835329-b306-15e8-e053-a505fe0a3de9 2
Efficacy and safety of PCSK9 monoclonal antibodies, file e3835329-c4ab-15e8-e053-a505fe0a3de9 2
Therapeutic apheresis in low weight patients: Technical feasibility, tolerance, compliance, and risks, file e3835311-6566-15e8-e053-a505fe0a3de9 1
Effetto dell'integrazione della dieta abituale con le fibre di glucomannano. Studio clinico nelle ipercolesterolemie familiari e sporadiche con fenotipo lipoproteico IIA e IIB, file e3835311-7d15-15e8-e053-a505fe0a3de9 1
LDL-apheresis in a homozygous familial hypercholesterolemic child aged 4.5, file e3835311-bc5e-15e8-e053-a505fe0a3de9 1
LDL-apheresis in a homozygous familial hypercholesterolemic child aged 4.5, file e3835311-bc61-15e8-e053-a505fe0a3de9 1
Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia, file e3835311-c463-15e8-e053-a505fe0a3de9 1
Apheresis-inducible cytokine pattern change in severe, genetic dyslipidemias, file e3835311-c46a-15e8-e053-a505fe0a3de9 1
Effects of selective H.E.L.P. LDL-apheresis on plasma cytokine concentrations in severe dyslipidemia: implication for anti-inflammatory response, file e3835311-c46b-15e8-e053-a505fe0a3de9 1
A three month-old infant with severe hyperchylomicronemia: Molecular diagnosis and extracorporeal treatment, file e3835311-e972-15e8-e053-a505fe0a3de9 1
Corticosteroidi prenatali: cosa c'è di nuovo?, file e3835311-f268-15e8-e053-a505fe0a3de9 1
Erratum to "Effects of selective H.E.L.P. LDL-apheresis on plasma inflammatory markers concentration in severe dyslipidemia: Implication for anti-inflammatory response", file e3835311-f91b-15e8-e053-a505fe0a3de9 1
Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group 2009 Survey, file e3835312-0e3a-15e8-e053-a505fe0a3de9 1
First prenatal diagnosis of familial hypercholesterolemia by a molecular biology technic, file e3835312-1b0a-15e8-e053-a505fe0a3de9 1
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study, file e3835312-2699-15e8-e053-a505fe0a3de9 1
Sustained LDL-C lowering and stable hepatic fat levels in patients with homozygous familial hypercholesterolemia treated with the Microsomal Triglyceride Transfer Protein Inhibitor, lomitapide: results of an ongoing long-term extension study, file e3835312-633d-15e8-e053-a505fe0a3de9 1
null, file e3835313-5f7b-15e8-e053-a505fe0a3de9 1
Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis, file e3835317-28f1-15e8-e053-a505fe0a3de9 1
Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances., file e383531d-f46f-15e8-e053-a505fe0a3de9 1
Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives, file e383531e-074c-15e8-e053-a505fe0a3de9 1
Scientific Information Security in Information Science and Academic Publishing, file e383531e-1793-15e8-e053-a505fe0a3de9 1
Lipoprotein apheresis and pcsk9-inhibitors. Impact on atherogenic lipoproteins and anti-inflammatory mediators in familial hypercholesterolaemia, file e383532a-73d2-15e8-e053-a505fe0a3de9 1
Totale 1.759
Categoria #
all - tutte 3.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201953 0 0 0 0 0 0 0 0 0 10 27 16
2019/2020138 12 8 3 8 11 12 19 15 17 10 14 9
2020/2021275 13 7 4 7 5 7 5 37 62 47 46 35
2021/2022635 22 44 34 113 93 34 34 32 40 22 115 52
2022/2023359 23 20 112 48 22 39 25 20 8 8 23 11
2023/2024249 20 15 33 19 61 23 30 29 8 11 0 0
Totale 1.759